Virology News

Survival of infection with Ebola virus (EBOV) depends on the ability of the host to mount early and strong immune responses [1], [2]. However, given that EBOV cases are associated with 40%–90% human mortality, EBOV has developed intricate solutions to human immunological defenses. Enveloped viruses, like EBOV, must deposit their genetic material within a cell to ensure their propagation. The roles of viral envelope glycoproteins in mediating virus attachment to host cells and catalyzing the subsequent fusion of the viral and host plasma membranes have been well described (reviewed in [3]). Given the limited number of genes in EBOV and other viruses, it stands to reason that these conformationally labile glycoproteins are also involved in more than just the initial steps of a productive infection. There is strong evidence that viral entry glycoproteins (GP) are modulators of host antiviral defenses (Table 1). In this article, we discuss our current structural understanding of the functions of envelope entry glycoproteins in immune evasion using EBOV as our example.

NIAID scientists and their collaborators travel to a remote village in the Republic of the Congo to search for Ebola

and other emerging viruses.

Vaccination has been successful at controlling many of the world’s diseases. However, there are many emerging viral diseases for which no licensed (US or EU) vaccine exists. Here I’ve selected 10 emerging or re-emerging viruses which I think are especially important due to their incidence, prevalence, morbidity, mortality and suitability of current treatment...

Ebola virus graphic courtesy of Russell Kightely Media

World Vaccine Congress & Expo 2013 

Dr Thomas P. Monath, Adjunct Professor at Harvard School of Public Health gives his presentation on ‘New vaccines needed for pathogens infecting animals and humans: One Health’.

Vaccination has been successful at controlling many of the world’s diseases. However, there are many emerging viral diseases for which no licensed (US or EU) vaccine exists. Here I’ve selected 10 emerging or re-emerging viruses which I think are especially important due to their incidence, prevalence, morbidity, mortality and suitability of current treatment.